Loading clinical trials...
Loading clinical trials...
A Phase 3 Multi-Center, Open Label Study Evaluating the Long Term Safety of SB204 Once Daily in the Treatment of Acne Vulgaris
Conditions
Interventions
SB204 4%
Locations
69
United States
CIL #138
Birmingham, Alabama, United States
CIL #218
Mobile, Alabama, United States
CIL #189
Phoenix, Arizona, United States
CIL #146
Anaheim, California, United States
CIL #139
Cerritos, California, United States
CIL #216
Chula Vista, California, United States
Start Date
May 12, 2016
Primary Completion Date
April 1, 2017
Completion Date
April 27, 2017
Last Updated
May 12, 2023
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT06415305
Lead Sponsor
Novan, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions